Induction of "in vitro" apoptosis by fludarabine in freshly isolated B-chronic lymphocytic leukemia cells

Leuk Lymphoma. 1994 Mar;13(1-2):95-7. doi: 10.3109/10428199409051657.

Abstract

The cytotoxic effects and apoptosis (programmed cell death) induced by fludarabine (FLU), interleukin-2 (IL-2), interleukin-4 (IL-4), IL-2 plus IL-4, alpha-interferon (alpha-IFN), and mafosfamide were evaluated "in vitro" on freshly isolated B-cell chronic lymphocytic leukemia (B-CLL) cells. Cytotoxicity was evaluated according to the soluble tetrazolium/formazan assay. Treatment with mafosfamide, fludarabine, and IL-4 resulted in significant anti-tumor activity against all the freshly isolated samples. On the other hand, no significant cytotoxic activity was observed with alpha-IFN, IL-2, and the combination of IL-2 and IL-4. Apoptosis was evaluated by electrophoresis gel of DNA oligonucleosomal fragments and only FLU significantly activated apoptosis in all the samples. It appears that fludarabine is active against B-CLL cells acting by an direct cytotoxic effect and/or the induction of cell death by apoptosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / toxicity*
  • Apoptosis / drug effects*
  • B-Lymphocytes / drug effects
  • B-Lymphocytes / immunology*
  • Cell Survival / drug effects
  • Cells, Cultured
  • Cyclophosphamide / analogs & derivatives
  • Cyclophosphamide / toxicity
  • Cytotoxicity, Immunologic / drug effects
  • Humans
  • Immunophenotyping
  • Interferon-alpha / pharmacology
  • Interleukin-2 / pharmacology
  • Interleukin-4 / pharmacology
  • Leukemia, Lymphocytic, Chronic, B-Cell / blood*
  • Leukemia, Lymphocytic, Chronic, B-Cell / immunology*
  • Lymphocyte Activation / drug effects
  • Tumor Cells, Cultured
  • Vidarabine / analogs & derivatives*
  • Vidarabine / toxicity

Substances

  • Antineoplastic Agents
  • Interferon-alpha
  • Interleukin-2
  • Interleukin-4
  • mafosfamide
  • Cyclophosphamide
  • Vidarabine
  • fludarabine